Ning S, Li Z, Ji Z, Fan D, Wang K, Wang Q, Hua L, Zhang J, Meng I, Yuan I (2020) MicroRNA-494 suppresses hypoxia/reoxygenation-induced cardiomyocyte apoptosis and autophagy via the PI3K/AKT/mTOR signaling pathway by targeting SIRT1
GLP-1 receptor agonists (semaglutide, liraglutide) are MHRA-approved medications that lower blood glucose and promote weight loss by mimicking a natural hormone
Pharmint can support sourcing conversations for qualified buyers in Vietnam, Nigeria, South Africa, Saudi Arabia, Canada, USA, EU, UK, Australia, and other reviewed destinations
Professional programs recognize that weight management involves more than just a medication
Participate and shape the future of obesity care